Titelia

Holdings of Kynam Capital Management, LP

30 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 76.4 % of the equity sleeve

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 96.3 %
  • KY 3.2 %
  • GB 0.5 %

Shares computed on the equity sleeve.

CountryLinesValueShare
US271.4B $96.31 %
KY248.3M $3.24 %
GB16.8M $0.46 %

Positions

CompanySharesValueWeight
Syndax Pharmaceuticals Inc 8,050,959188.1M $
Celldex Therapeutics Inc 5,840,567185.3M $
Vaxcyte Inc 2,922,335169.8M $
Cogent Biosciences Inc 4,037,331155.4M $
Vera Therapeutics Inc 3,398,224136.7M $
Beam Therapeutics Inc 3,682,18587.7M $
CytomX Therapeutics Inc 15,013,09370.6M $
BioCryst Pharmaceuticals Inc 5,680,79554.1M $
Travere Therapeutics Inc 1,569,01846.6M $
Viridian Therapeutics Inc 2,341,65245.8M $
Cullinan Therapeutics Inc 3,114,13244.3M $
KalVista Pharmaceuticals Inc 1,820,95436.7M $
Apellis Pharmaceuticals Inc 825,00033.2M $
LEGEND BIOTECH CORP 1,576,29528.5M $
MBX Biosciences Inc 934,79927.9M $
Immunocore Holdings PLC 884,93726.7M $
Sutro Biopharma Inc 872,55821.7M $
Burning Rock Biotech Ltd 1,227,55519.8M $
Soleno Therapeutics Inc 560,00018.7M $
Nurix Therapeutics Inc 1,194,75718.5M $
Evommune Inc 625,49614.4M $
Relay Therapeutics Inc 1,424,25914.2M $
Geron Corp 6,836,31810.2M $
Design Therapeutics Inc 784,6068.3M $
Climb Bio Inc 1,003,3416.9M $
Amarin Corp PLC 472,3826.8M $
Prelude Therapeutics Inc 1,592,5515.4M $
Caribou Biosciences Inc 2,503,3024.8M $
Alector Inc 2,000,0004.3M $
Candel Therapeutics Inc 200,000980K $